Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
668
datasets available to search
ShareScore release 0.9.0
Dataset results
668 results for “Everolimus”
Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
ClinicalTrials.gov study NCT01888432. IPD Sharing: UNDECIDED. Countries: 13. Publications: 1.
Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)
ClinicalTrials.gov study NCT01524783. IPD Sharing: YES. Countries: 25. Publications: 5.
A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.
ClinicalTrials.gov study NCT01783444. IPD Sharing: YES. Countries: 18. Publications: 1.
Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
ClinicalTrials.gov study NCT01698918. IPD Sharing: YES. Countries: 13. Publications: 1.
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
ClinicalTrials.gov study NCT01713946. IPD Sharing: YES. Countries: 25. Publications: 3.
Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation
ClinicalTrials.gov study NCT00377962. IPD Sharing: UNDECIDED. Countries: 3. Publications: 3.
A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-s
ClinicalTrials.gov study NCT03312738. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen
ClinicalTrials.gov study NCT01544491. IPD Sharing: UNDECIDED. Countries: 13. Publications: 2.
Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
ClinicalTrials.gov study NCT01950819. IPD Sharing: UNDECIDED. Countries: 42. Publications: 5.
Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00876395. IPD Sharing: UNDECIDED. Countries: 28. Publications: 3.
Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients
ClinicalTrials.gov study NCT01404325. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
ClinicalTrials.gov study NCT01734512. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)
ClinicalTrials.gov study NCT04195750. IPD Sharing: YES. Countries: 23. Publications: 2.
Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program
ClinicalTrials.gov study NCT00956293. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
ClinicalTrials.gov study NCT01025817. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative
ClinicalTrials.gov study NCT02456857. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
ClinicalTrials.gov study NCT01125293. IPD Sharing: NO. Countries: 1. Publications: 1.
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
ClinicalTrials.gov study NCT00553150. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01154335. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
ClinicalTrials.gov study NCT01797120. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.